BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A. Type I interferon-related kidney disorders. Kidney Int 2022:S0085-2538(22)00213-7. [PMID: 35339535 DOI: 10.1016/j.kint.2022.02.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Trivioli G, Marquez A, Martorana D, Tesi M, Kronbichler A, Lyons PA, Vaglio A. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. Nat Rev Rheumatol. [DOI: 10.1038/s41584-022-00819-y] [Reference Citation Analysis]
2 Rafat C, Doreille A. Could Plasmodium falciparum-related kidney disease stand as another example of interferonopathy? Kidney Int 2022;102:669-70. [PMID: 35988939 DOI: 10.1016/j.kint.2022.06.009] [Reference Citation Analysis]
3 Trivioli G, Gelain E, Angelotti ML, Ravaglia F, Allinovi M, Lodi L, Caroti L, Buccoliero A, Emmi G, Gattorno M, Romagnani P, Volpi S, Vaglio A. A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon. Am J Kidney Dis 2022:S0272-6386(22)00767-3. [PMID: 35817275 DOI: 10.1053/j.ajkd.2022.05.008] [Reference Citation Analysis]
4 Skopelja-Gardner S, An J, Elkon KB. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nat Rev Nephrol 2022. [PMID: 35732833 DOI: 10.1038/s41581-022-00589-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]